$GTBIF

Green Thumb Industries reported Q2 2026 sales of US$306.68 million and net income of US$4.88 million, returning to profitability versus a prior-year net loss, according to the company. It also announced share repurchases of US$48.3 million in the quarter and discussed adult-use cannabis market developments in Virginia and New Jersey.

Green Thumb Industries Inc. (GTBIF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gtbif-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Green Thumb Industries Reports Second Quarter 2026 Results CHICAGO and VANCOUVER, British Columbia, August 4, 2026 (GLOBE NEWSWIRE) – Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a

Green Thumb Industries reported Q1 revenue up 7.4% year over year to $300.2 million, with $76.0 million in operating cash flow and $93.5 million in normalized EBITDA. GAAP net income was $15.4 million. The company ended Q1 with about $344.5 million cash and $289.9 million total debt and repurchased about 6 million shares for $33.3 million.

Lollapalooza in Chicago is serving hemp-derived THC drinks for the first time, supplied by RYTHM, a Green Thumb Industries brand. The Señorita 12-ounce cans (Mango Margarita, Lime Jalapeño) contain 5 mg hemp THC. Green Thumb CEO Ben Kovler said demand is shifting away from alcohol. Illinois rules effective in November may limit sales outside licensed dispensaries.

President Trump showed support for looser regulations in the cannabis industry even before he was elected for his second term in office. For instance, he supported an initiative in his home state of Florida that aimed at making recreational use of marijuana legal for adults. And since he took office for his second term, there has been significant progress in the industry. Products containing marijuana approved by the U.S.

According to recent Federal Election Commission filings, major cannabis firms Verano, Curaleaf, Trulieve and Vision Management Services each donated $2.5 million to the Trump-aligned America First Agriculture Action Inc. Ascend Wellness and Arboretum Bidco added $500,000 and $1 million. Trulieve also gave $250,000 to another GOP super PAC. The article links the spending to lobbying over hemp versus marijuana regulation.

Trump’s executive order directed the DEA to reschedule marijuana from Schedule I to Schedule III, enacted in April by acting Attorney General Todd Blanche. The change applies to medical cannabis, potentially removing IRS Section 280E limits on deductions. The article says Canopy Growth and Tilray are only incrementally affected, while Green Thumb’s medical impact is unclear due to limited segment disclosure.

Green Thumb Industries Inc. (GTBIF) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. EX-3.1 2 gtbif-ex3_1.htm EX-3.1 EX-3.1 AMENDED AND RESTATED ARTICLES OF GREEN THUMB INDUSTRIES INC. DOCPROPERTY "CUS_DocIDChunk0" NATDOCS\94464328\V-1 INDEX TO THE AMENDED AND RESTATED ARTICLES OF GREEN THUMB INDUSTRIES INC. Continuation Number: C776592 (the “Company”) PART 1 - I

On April 23, the U.S. DOJ rescheduled cannabis from Schedule I to Schedule III, which the article says could reduce the 280E federal tax burden for state-licensed medical operators. Green Thumb Industries reported Q1 revenue of $300.2M (+7.4% YoY) and EPS of $0.07 (+75%), with cash of $344.5M. The company said it filed for DEA registrations and bought back $33.3M of shares.

The article compares U.S. multi-state cannabis operators Green Thumb Industries (GTBIF) and Curaleaf Holdings (CURLF). It says Curaleaf is the largest MSO by TTM sales (~$1.3B) versus Green Thumb (~$1.2B). Both face regulatory and tax uncertainty under IRS Section 280E. Green Thumb has positive GAAP EPS for five years and trades at ~3.5x EV/EBITDA versus Curaleaf ~15.5x, while Curaleaf targets Europe and plans an OTC-to-exchange uplisting pending approval.